New cell therapy trial opens for Tough-to-Treat cancers
Disease control
Not yet recruiting
This early-stage study is testing a new cell-based treatment called SL-28 in adults with advanced solid tumors that have not responded to standard therapies. The main goals are to find the safest and most effective dose and to check for side effects. Participants will receive the…
Phase: PHASE1, PHASE2 • Sponsor: Second Life Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC